Home | Welcome to Contract Pharma   
Last Updated Sunday, December 21 2014

Print

Breaking News

Related Searches:
May 20, 2011
Fereydoun Firouz has resigned from his position as president and chief executive officer of EMD Serono, Inc., an affiliate of Merck KGaA.  Read More »
May 20, 2011
BioAegis Therapeutics has entered into an exclusive option agreement with Brigham and Women’s Hospital granting BioAegis a worldwide license for therapeutic and diagnostic use of Brigham’s technology for human and animal applications.   Read More »
May 20, 2011
Accovion has expanded with a new subsidiary in the UK and has appointed Carl Naraynassamy as managing director.   Read More »
May 19, 2011
Takeda Pharmaceutical Co. Ltd. has reached an agreement to acquire Nycomed for $13.7 billion on a cash-free, debt-free basis.  Read More »
May 19, 2011
Lonza is expanding its viral-based therapeutics business with the construction of a new, cGMP clean room at its Houston, TX operations.   Read More »
May 19, 2011
Thermo Fisher Scientific, Inc. has signed a definitive agreement to acquire Phadia, a global allergy and autoimmunity diagnostics firm, from European private equity firm Cinven, for approximately $3.5 billion in cash.   Read More »
May 19, 2011
Vyteris, Inc. is realigning the company in an effort to become a diversified specialty CRO.  Read More »
May 19, 2011
Vetter has completed the structural work for its new German facility Ravensburg Vetter West.  Read More »
May 18, 2011
Thermo Fisher Scientific, Inc. has acquired Sterilin, Ltd., a provider of single-use plastic products for the microbiology, life sciences and clinical markets.   Read More »
May 18, 2011
Ropack began stickpack production at its new 15,000-sq.-ft dedicated manufacturing suite.  Read More »
May 18, 2011
Goodwin Biotechnology, Inc. (GBI) and Rafagen, Inc. have entered a collaboration agreement for cell line engineering and biological contract manufacturing.   Read More »
May 18, 2011
Ronald Kershner, Ph.D. has been appointed vice president, Biostatistics and Data Operations, North America for Premier Research Group Ltd.   Read More »
May 17, 2011
Move adds global clinical network to CRO  Read More »
May 17, 2011
Tekmira Pharmaceuticals has expanded its multi-year collaboration with Bristol-Myers Squibb to include newly developed Tekmira proprietary lipid nanoparticle (LNP) formulations for delivery to tumors and other tissues outside the liver.  Read More »
May 17, 2011
Pfizer’s NDA for crizotinib, an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of ALK-positive advanced non-small cell lung cancer (NSCLC), has been accepted for filing and granted Priority Review status by the FDA.  Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On